AI drug discovery market to grow 30% CAGR, to reach US$ 35 bn by 2034; Novo, Lilly, BMS forge deals

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

(1Z)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N'-sulfamoylpropanimidamide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

62 API Suppliers, 24 USDMF, 16 CEP/COS, 13 JDMF, 16 EU WC, 34 KDMF, 26 NDC API, 36 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

18 Intermediate Suppliers

18 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

223 FDF Dossiers, 144 FDA Orange Book, 24 Europe, 17 Canada, 2 Australia, 36 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 40MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Evonik, 7 Rochem International Inc, 18 SPI Pharma, 9 DKSH, 2 Pharm-RX Chemical, 9 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 10 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 30 BASF, 1 Bioplus Life Sciences, 2 Clariant, 13 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 18 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 10 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 28 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

92 Fillers, Diluents & Binders, 71 Coating Systems & Additives, 39 Controlled & Modified Release, 38 Thickeners and Stabilizers, 35 Solubilizers, 34 Disintegrants & Superdisintegrants, 34 Direct Compression, 29 Taste Masking, 28 Granulation, 23 Parenteral, 22 Topical, 18 Chewable & Orodispersible Aids, 17 Lubricants & Glidants, 16 Film Formers & Plasticizers, 16 Co-Processed Excipients, 13 Rheology Modifiers, 10 Emulsifying Agents, 8 API Stability Enhancers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 4 Coloring Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 61 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 31 Regulatory FDF Prices, 3 Annual Reports

MARKET PLACE

42 APIs, 42 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 US Patents, 4 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 6 USP, 16 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
30/12/2024	Alembic Pharmaceuticals Limited	India	Pharmapia Co., Ltd.	20240318-67-B-476-15	Famotidine	2024-03-18	Alembic Pharmaceuticals Limited (API Unit-I)	India	AT-Panelav, PO Tajpura, Nr. Baska, Tal-Halol, City: Panelav, Dist: Panchmahal, Gujarat State, 389350, India
30/12/2024	Gedeon Richter	Hungary	Dong-A ST Co., Ltd.	20180208-67-B-407-09	Famotidine	2018-02-08	Gedeon Richter Plc.	Hungary	Gyomroi ut 19-21., Budapest, 1103, Hungary

(1Z)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N'-sulfamoylpropanimidamide

(1Z)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N'-sulfamoylpropanimidamide

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

62 API Suppliers

24 USDMF

16 CEP/COS

13 JDMF

16 EU WC

34 KDMF

26 NDC API

36 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

INTERMEDIATES

18 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

223 FDF Dossiers

144 FDA Orange Book

24 Europe

17 Canada

2 Australia

36 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FOR SUSPENSION;ORAL - 40MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Evonik

7 Rochem International Inc

18 SPI Pharma

9 DKSH

2 Pharm-RX Chemical

9 Faran Shimi Pharmaceutical

1 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 ACG Worldwide

10 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Avesta Pharma

30 BASF

1 Bioplus Life Sciences

2 Clariant

13 Corel Pharma Chem

7 DFE Pharma

2 Finar

12 Gangwal Chemicals

11 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

39 Kerry

4 Kima Chemical

6 Lonza Capsugel

18 Microlex e.U

1 Nanjing Bold Chemical

2 Nomisma Healthcare

3 Novo Excipients

3 Pharmatrans-Sanaq

10 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

28 Roquette

13 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

12 Sigachi Industries

3 The Dow Chemical Company

1 Valens Pharmachem

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

92 Fillers, Diluents & Binders

71 Coating Systems & Additives

TABLET;ORAL - 20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

FOR SUSPENSION;ORAL - 40MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons